Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

The endocannabinoid N-arachidonoyl dopamine (NADA) selective — 2012 Review/Other | BudProfiles

Home

Studies

The endocannabinoid N-arachidonoyl dopamine (NADA)...

PositiveReview/Other2012

The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Fibrosis - Liver (Cirrhosis)Fibrosis

Related Studies

Inconclusive

Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis

2025·Review/Other

Inconclusive

P453 A study on patient and healthcare provider experiences with outpatient sexual and reproductive healthcare for adults with cystic fibrosis: insights from a single-center study

2025·Review/Other

Positive

Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis

2025·Review/Other

Positive

Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy

2024·Animal Study -

Inconclusive

Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present)

2024·Review/Other

Positive

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury

2022·Review/Other

Cannabinoids

N-Arachidonoyl Dopamine (NADA)

Organ Systems

Digestive System

Study Details

Type: Review/Other
Year: 2012
Study ID: #2012109